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e-mail address: furuta@fmu.ac.jp (M. Furuta).Minoru Furuta, MD ⇑; Tetsuju Sekiryu, MD; Akihito Kasai, MD; Yasuharu Oguchi, MDAbstractPurpose: To clarify and review the early and late morphologic changes of the macula associating with visual loss in patients with
subfoveal fluid secondary to extrafoveal circumscribed choroidal hemangiomas.
Methods: Previously six non-treated eyes of six patients with subfoveal retinal detachment secondary to extrafoveal circumscribed
choroidal hemangioma were included. Visual acuity (VA), duration of visual symptoms, color fundus photography, optical coher-
ence tomography (OCT), fundus autofluorescence, and fluorescein angiography (FA) were evaluated.
Results: The mean patient age was 58 years (range, 25–78). The VA and duration of symptoms in each patient was 1.2 (3 days), 0.6
(1 week), 0.4 (3 months), 0.5 (6 months), 0.02 (12 months), and 0.01 (8 years), respectively. Three patients with symptoms for less
than 3 months did not have retinal pigment epithelial (RPE) alterations, retinal edema, or thinning of the retinal structure in the
fovea. A patient with symptoms for 3 months had subfoveal deposits underneath the detached neurosensory retina with foveal
hyperautofluorescence. Two patients with symptoms exceeding 12 months had highly affected RPE and cystoid macular
degeneration.
Conclusions: The VA was affected in patients with longer visual symptoms, and there are some changes in the retina and RPE in
the fovea by FA and OCT. Persistent subretinal fluid secondary to choroidal hemangiomas may result in pathologic changes in the
neurosensory retina.
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Circumscribed choroidal hemangioma is a benign, vascu-
lar, hamartomatous tumor generally detected at the poster-
ior pole of the ocular fundus as a solitary lesion without
systemic findings.1,2 The typical characteristics of this tumor
include an orange-red color, an echodense appearance on
ultrasonography, and early hyperfluorescence with fluores-
cein and indocyanine green angiography3,4 Shields et al.5 re-ported that the visual acuity (VA) at the initial presentation
decreased profoundly to 20/200 or worse in 54% of patients
with circumscribed choroidal hemangioma, and the patho-
genesis of visual loss generally is associated with a serous ret-
inal detachment. Persistent macular detachment can cause
various morphologic changes in the sensory retina and retinal
pigment epithelium (RPE), including cystoid macular changes
and RPE atrophy as in chronic central serous chorioretinopa-
thy (CSC).6 These changes account for poor visual prognoses.e:
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Figure 1. Patient 1. A 64-year-old man with 1.2 of visual acuity (VA) with a 3-day duration of visual symptoms in the right eye. (a) Color fundus
photograph shows a red–orange choroidal mass inferior to the foveola. (b) Optical coherence tomography (OCT) shows localized subfoveal fluid. (c)
Fundus autofluorescence (FAF) image shows foveal isoautofluorescence. (d) Fluorescein angiography (20 s) shows localized retinal pigment epithelial
(RPE) changes. (e) Fluorescein angiography (3 min) shows mild RPE leakage. (f) Color fundus photograph after 6 months follow-up. The VA decreased to
0.6. (g) OCT shows increasing subfoveal fluid and deposits on the outer surface of the sensory retina. (h) A FAF image shows increasing
hyperautofluorescence.
210 M. Furuta et al.We studied the relationships between the macular find-
ings and VA in six patients (6 eyes) with subfoveal retinal
detachment secondary to extrafoveal circumscribed choroi-
dal hemangiomas with regard to the initial presentation.Materials and methods
We reviewed the digital medical records in the Depart-
ment of Ophthalmology, Fukushima Medical University Hos-
Figure 2. Patient 3. A 49-year-old man with 0.4 of VA with 3-months duration of visual symptoms in the right eye. (a) A color fundus photograph shows
an orange choroidal mass temporal to the foveola. (b) OCT shows subfoveal fluid and deposits on the outer surface of the sensory retina. (c) Fluorescein
angiography (1 min) shows hyperfluorescence of the choroidal mass and negative fluorescence at the foveola suggesting an intact RPE. (d) A FAF image
shows foveal hyperautofluorescence.
Figure 3. Patient 5. A 55-year-old man with 0.02 VA with a 12-month duration of visual symptoms in the right eye. (a) A color fundus photograph shows
an orange choroidal mass inferior to the foveola. (b) OCT shows cystic macular changes. (c) Fluorescein angiography (1 min) shows diffuse macular
hyperfluorescence and a choroidal mass. (d) Fluorescein angiography (5 min) shows diffuse macular staining and a choroidal mass. There is no dye
pooling in the cystic space at the fovea. (e) A FAF image shows hypoautofluorescence at the fovea.
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Table 1. Characteristics of extrafoveal circumscribed choroidal hemangioma with subfoveal fluid and imaging findings in six eyes.
Patient Age/
gender
Duration of
visual
symptoms
Initial
visual
acuity
Tumor
diameter
(mm)
Proximity to
foveola (mm)
Quadrantal
tumor
location
OCT findings FA (RPE
alterations at
fovea)
FAF of fovea
1 64/M 3 days 1.2 6.0 1.0 Inferior SRF Local Isofluorescence
2 25/F 1 week 0.6 9.0 3.5 Nasal SRF No NE
3 49/M 3 months 0.4 6.0 3.0 Temporal SRF + deposits No Hyperfluorescence
4 74/F 6 months 0.5 8.0 3.0 Superior SRF + deposits Local NE
5 55/M 12 months 0.02 5.0 1.5 Inferior CMD Diffuse Hypofluorescence
6 78/F 8 years 0.01 6.0 2.0 Superior CMD Diffuse NE
M, male; F, female; OCT, optical coherence tomography; SRF, subretinal fluid; CMD, cystoid macular degeneration; FA, fluorescein angiography; RPE, retinal pigment epithelium;
FAF, fundus autofluorescence; NE, not examined.
212 M. Furuta et al.pital, Fukushima, Japan, and identified six previously
non-treated eyes of six patients with well-documented
extrafoveal circumscribed choroidal hemangioma with visual
symptoms due to subfoveal retinal detachment. The patient
data included age, gender, VA, duration of visual symptoms,
tumor diameter, quadrantic location of the tumor epicenter,
proximity to the foveola, color fundus photography, optical
coherence tomography (OCT) (Stratus OCT, Model 3000,
Carl Zeiss Ophthalmic System, Dublin, CA, and 3D OCT-
1000, Topcon, Tokyo, Japan), fundus autofluorescence
(FAF) (Heidelberg Retina Angiograph 2 [HRA2], Heidelberg
Engineering, Dossenheim, Germany), and fluorescein angi-
ography (FA) (TRC-50IX, Topcon, Tokyo, Japan) at the initial
presentation. Ancillary test results were reviewed regarding
ultrasonography (A- and B-scans), magnetic resonance imag-
ing (T1- and T2-weighted images), FA (prearterial, arterial, ve-
nous, and late phase), and indocyanine green angiography
(ICGA) (early, middle, and late phases).
This study was conducted in accordance with the Declara-
tion of Helsinki and Good Clinical Practice Guidelines. All pa-
tients consented to the use of the data for research. This
study followed the tenets of the Declaration of Helsinki.
The institutional review board at the Fukushima Medical Uni-
versity School of Medicine approved the methods used in this
study, including observation using OCT and FAF for eyes
with macular and retinal disorders.Results
Six eyes of six patients (3 men, 3 women) with subfoveal
fluid secondary to extrafoveal circumscribed choroidal hem-
angioma were included. They had no history of ocular treat-
ment. The mean patient age at the initial presentation was
58 years (range, 25–78). The duration of symptoms ranged
from 3 days to 8 years. In patients with a longer duration of
symptoms, the VA decreased 1.2 into 0.01; however, age,
gender, tumor diameter, proximity to the foveola, and qua-
drantal location of the tumor were inconsistent with it. Both
the patient and tumor characteristics are listed in the Table 1
Two patients with symptoms for over 12 months had clearly
decreased vision (patients 5 and 6 in the Table 1).
The findings on OCT, FA, and FAF are shown in Table 1
OCT showed various macular changes. Patients 1 and 2,
who had symptoms for 1 week or less, had subfoveal fluid
accumulation with mild RPE alterations on FA with isoautoflu-
orescence (Fig. 1). Patients 3 and 4 who had symptoms for 3
to 6 months had deposits on the outer surface of the de-
tached neurosensory retina with hyperautofluorescence(Fig. 2). One patient (Fig. 1) had decreased VA by 6 months’
observation and deposits on the outer surface of the sensory
retina and increasing hyperautofluorescence. Patients 5 and
6 who had symptoms for 12 months or longer had cystic mac-
ular change with diffuse RPE alterations and late staining on
FA and hypoautofluorescence (Fig. 3).Discussion
Circumscribed choroidal hemangioma is a benign tumor
comprised of endothelium-lined, vascular channels that in-
volve the full choroidal thickness with secondary changes in
the overlying RPE and retina.7 Visual loss generally is caused
by transudative leakage and accumulated subretinal fluid.1
Other mechanisms that may result in visual loss include sub-
foveal location of the tumor, macular edema, RPE alterations
in the macula, pigment migration, subretinal fibrosis, and are-
olar macular atrophy.8
Shields et al.5 reported that 81% of patients had a second-
ary retinal detachment in the fovea and 53% of patients had
poor VA of 20/200 or worse at the initial presentation; 54% of
the patients with poor initial vision were predicted to have
poor final vision after 5 years. Factors predictive of poor final
VA include a poor initial VA and management consisting only
of observations after referral.
The pathogenesis of the retinal detachment in patients
with circumscribed choroidal hemangioma is leakage from
the RPE seen on FA. A similar mechanism of leakage occurs
in patients with CSC, acute exudative polymorphous vitelli-
form maculopathy, choroidal melanoma, and choroidal
nevus.
Iida et al.9 and Furuta et al.10 have reported morphologic
changes in the acute and chronic phases of CSC. In the acute
phase, the detached neurosensory retina is thickened and the
VA is good before and after resolution of the subretinal fluid.
In the chronic phase, cystoid macular degeneration, i.e., the
presence of cystic macular changes without dye pooling to
the cystic space in conjunction with foveal atrophy, leads to
poor visual outcome.6
A result of a recent FAF study led to a hypothesis concern-
ing the mechanisms of visual loss in patients with serous ret-
inal detachment including CSC, circumscribed choroidal
hemangioma, adult-onset foveomacular vitelliform dystro-
phy, and optic pit maculopathy; Separation of the outer ret-
ina from the RPE prevents proper phagocytosis of the
photoreceptor outer segment. Increased accumulation of
degenerated, shed photoreceptors visible as an increasingly
thick coating on the outer retina creates more autofluores-
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cytized by macrophages capable of inducing damage in the
neurosensory retina and RPE. These processes may eventu-
ally lead to retinal thinning, RPE atrophy, and visual loss.11
A part of these pathological changes are clinically observed
by sampling the subretinal fluid, which proves the macro-
phages in the subretinal fluid possess autofluorescence that
is spectroscopically similar to lipofuscin and autofluorescence
of macrophages can be attributed to degenerated outer seg-
ments and debris from apoptotic photoreceptors.12 Rama-
subramanian et al.13 uniquely studied the autofluorescence
features of 34 consecutive choroidal hemangiomas, and sta-
ted that overlying orange pigment and fresh subretinal fluid
show hyperautofluorescence and RPE hyperplasia and atro-
phy show hypoautofluorescence.
Some studies have evaluated the relationship between VA
and the clinical features of the circumscribed choroidal hem-
angioma.5,14,15 However, early morphologic foveal changes
due to retinal detachment from remote circumscribed choroi-
dal hemangioma have not been well discussed. In the current
report, the VA decreased based on the duration of visual
symptoms. Patients with longer symptoms had increased
deposits on the outer retinal surface presenting in a se-
quence of hyperautofluorescence, RPE alterations, and cystic
macular changes without dye pooling referred to as cystic
macular degeneration.6 Persistent subfoveal fluid may act
with similar mechanisms to cause permanent visual loss in pa-
tients with extrafoveal circumscribed choroidal hemangioma
and those with CSC.
Although the current study was limited in that it was a
small retrospective case series with all patients evaluated in
one referral center, a relationship between the pathogenesis
of visual loss and morphologic macular changes on FA and
FAF was clinically documented. OCT and FAF can detect
morphologic and functional macular changes before visual
loss. One risk factor for poor visual prognosis is follow-up
that includes only observation,5 and any visual symptoms
with persistent subfoveal fluid may lead to irreversible
changes to the sensory retina and RPE. Early direct treatment
of the tumor should be considered by photodynamic ther-
apy16,17 if circumscribed choroidal hemangioma is seen extra-
foveally with subfoveal fluid. Further studies of morphologic
and functional observations are needed in patients with
early-phase visual impairment.
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